We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.37B
1-Year Est. Return
71.68%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+71.68%
3 Year Est. Return
+198.05%
5 Year Est. Return
+324.32%
10 Year Est. Return
+2,686.25%
AUM
$1.65B
AUM Growth
+$213M
(+15%)
Cap. Flow
+$40M
Cap. Flow
% of AUM
2.42%
Top 10 Holdings %
Top 10 Hldgs %
13.99%
Holding
1,616
New
434
Increased
384
Reduced
359
Closed
375
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elastic
ESTC
|
+$6.65M |
| 2 |
K
Kellanova
K
|
+$6.45M |
| 3 |
Core Scientific
CORZ
|
+$5.85M |
| 4 |
ProShares Bitcoin Strategy ETF
BITO
|
+$5.79M |
| 5 |
GTM
ZoomInfo Technologies
GTM
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
+$11.1M |
| 2 |
Western Digital
WDC
|
+$8.43M |
| 3 |
Harmonic Inc
HLIT
|
+$7.72M |
| 4 |
NetEase
NTES
|
+$7.33M |
| 5 |
Fortrea Holdings
FTRE
|
+$6.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.97% |
| 2 | Technology | 14.94% |
| 3 | Consumer Discretionary | 9.59% |
| 4 | Healthcare | 9.5% |
| 5 | Industrials | 8.54% |
Similar funds
CA
MCI
WC
OCAI
AIP
FBCM
FCM
KPF
Prelude Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Prelude Capital Management held 1,616 positions worth $1.65B, up 15% from $1.44B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Prelude Capital Management's Q3 2024 filing shows 434 new, 384 increased, 359 reduced and 375 closed positions. Its largest new stake was Kellanova: 90,625 shares worth $7.31M. The largest sale was Cerevel Therapeutics Holdings, Inc. Common Stock, an estimated $11.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Prelude Capital Management's largest Q3 2024 buy was Kellanova: 90,625 shares worth $7.31M.
- Prelude Capital Management added most to Elastic in Q3 2024, an estimated $6.65M increase.
- Prelude Capital Management's biggest Q3 2024 reduction was Western Digital, cutting an estimated $8.43M.
- Prelude Capital Management fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $11.1M.
- Prelude Capital Management's ten largest holdings make up 14% of its $1.65B portfolio in Q3 2024.
- Prelude Capital Management opened 434 new positions and closed 375 in Q3 2024.
- Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $1.65B.
Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.